Falcipain Inhibitors: Optimization Studies of the 2-Pyrimidinecarbonitrile Lead Series-Reference-Cited by-同舟云学术

Falcipain Inhibitors: Optimization Studies of the 2-Pyrimidinecarbonitrile Lead Series

Published:2010-07-30 Issue:16 Volume:53 Page:6129-6152
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Coterón Jose M.¹,Catterick David²,Castro Julia¹,Chaparro María J.¹,Díaz Beatriz¹,Fernández Esther¹,Ferrer Santiago³,Gamo Francisco J.³,Gordo Mariola¹,Gut Jiri⁴,de las Heras Laura¹,Legac Jennifer⁴,Marco Maria¹,Miguel Juan¹,Muñoz Vicente¹,Porras Esther¹,de la Rosa Juan C.¹,Ruiz Jose R.¹,Sandoval Elena¹,Ventosa Pilar¹,Rosenthal Philip J.⁴,Fiandor Jose M.¹

Affiliation:

1. Department of Drug Discovery Chemistry

2. GlaxoSmithKline, Synthetic Chemistry, Old Powder Mills, Tonbridge, Kent, TN11 9AN, U.K.

3. Department of Drug Discovery Biology

4. Department of Medicine, San Francisco General Hospital, University of California, San Francisco, Box 0811, San Francisco, California 94143

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm100556b

Reference39 articles.